Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Experimental Anti-Body, MOR202, To Be Featured In New Phase One Study Next Year

Home/Experimental Anti-Body, MOR202, To Be Featured In New Phase One Study Next Year

Experimental Anti-Body, MOR202, To Be Featured In New Phase One Study Next Year

Hello from cold (for Florida) sunny Orlando!  ASH starts later today, but I’m getting an early start.  Still plenty to learn and share. For those of you who just can’t get enough multiple myeloma related technical information, here is a link to a power point presentation about an experimental anti-myeloma anti-body, MOR202.

Lots of photos, charts and graphs.  The bottom line:  After successful pre-clinical trial results, creator of the MOR202 anti-body, Morphosys, expects to begin enrolling patients for their first Stage 1 human study in in Germany next year.

Feel good and keep smiling!  Pat